Advanced Health Intelligence Ltd. (NASDAQ:AHI) Short Interest Update

Advanced Health Intelligence Ltd. (NASDAQ:AHI – Get Rating) was the recipient of a large decrease in short interest during the month of December. As of December 30th, there was short interest totalling 159,800 shares, a decrease of 35.6% from the December 15th total of 248,300 shares. Based on an average daily volume of 242,100 shares, the short-interest ratio is currently 0.7 days.

Institutional Trading of Advanced Health Intelligence

Several large investors have recently bought and sold shares of AHI. OLD Mission Capital LLC purchased a new stake in Advanced Health Intelligence during the 3rd quarter valued at about $37,000. Jane Street Group LLC purchased a new stake in Advanced Health Intelligence during the 1st quarter valued at about $33,000. Finally, Renaissance Technologies LLC purchased a new stake in Advanced Health Intelligence during the 1st quarter valued at about $29,000. Hedge funds and other institutional investors own 1.15% of the company’s stock.

Advanced Health Intelligence Stock Performance

AHI opened at $0.48 on Friday. Advanced Health Intelligence has a twelve month low of $0.35 and a twelve month high of $3.94. The company has a 50-day moving average price of $0.44 and a 200 day moving average price of $0.55.

Advanced Health Intelligence Company Profile

(Get Rating)

Advanced Health Intelligence Ltd. operates as a mobile application and technology development company in Australia and internationally. It develops and patents BodyScan, a proprietary measurement/dimensioning technology that enables end-user to check and assess body dimensions using a smartphone. The company also provides FaceScan for measuring vital signs, and risks associated with cardiovascular disease, heart attack, and stroke; and DermaScan, a dermatological scanner.